Long-Term Assets: The sum of all assets classified as non-current.
REGENXBIO Inc. (RGNX) had Long-Term Assets of $171.75M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$30.34M |
|
$-67.15M |
|
$5.93M |
|
$24.41M |
|
$87.97M |
|
$-57.64M |
|
$-9.51M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-67.15M |
|
$-57.64M |
|
-- |
|
51.75M |
|
51.75M |
|
$-1.30 |
|
$-1.30 |
|
| Balance Sheet Financials | |
$281.28M |
|
$104.86M |
|
|
Long-Term Assets |
$171.75M |
$453.03M |
|
$118.09M |
|
-- |
|
$232.20M |
|
$350.30M |
|
$102.73M |
|
$102.73M |
|
$102.73M |
|
50.89M |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|